相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Simplified murine multipotent progenitor isolation scheme: Establishing a consensus approach for multipotent progenitor identification
Grant A. Challen et al.
EXPERIMENTAL HEMATOLOGY (2021)
PI3K alpha and delta promote hematopoietic stem cell activation
Shayda Hemmati et al.
JCI INSIGHT (2019)
Alectinib for advanced ALK-positive non-small-cell lung cancer
Ashley C. Ly et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2018)
Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms
William Vainchenker et al.
BLOOD (2017)
Ceritinib: A primer for pharmacists
Trang H. Au et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2017)
Myeloproliferative neoplasms: A decade of discoveries and treatment advances
Ayalew Tefferi
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Roles of c-Met and RON Kinases in tumor progression and their potential as therapeutic targets
Katherine Chang et al.
ONCOTARGET (2015)
Searching for Drug Synergy in Complex Dose-Response Landscapes Using an Interaction Potency Model
Bhagwan Yadav et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2015)
Restoration of response to ruxolitinib upon brief withdrawal in two patients with myelofibrosis
Heinz Gisslinger et al.
AMERICAN JOURNAL OF HEMATOLOGY (2014)
Identification of Regulatory Networks in HSCs and Their Immediate Progeny via Integrated Proteome, Transcriptome, and DNA Methylome Analysis
Nina Cabezas-Wallscheid et al.
CELL STEM CELL (2014)
The Hepatocyte Growth Factor (HGF)/Met Axis: A Neglected Target in the Treatment of Chronic Myeloproliferative Neoplasms?
Marjorie Boissinot et al.
CANCERS (2014)
MSP-RON signalling in cancer: pathogenesis and therapeutic potential
Hang-Ping Yao et al.
NATURE REVIEWS CANCER (2013)
Heterodimeric JAK-STAT activation as a mechanism of persistence to JAK2 inhibitor therapy
Priya Koppikar et al.
NATURE (2012)
JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis
Claire Harrison et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
High-resolution kinetics of cytokine signaling in human CD34/CD117-positive cells in unfractionated bone marrow
Philip G. Woost et al.
BLOOD (2011)
Normal bone marrow signal-transduction profiles: a requisite for enhanced detection of signaling dysregulations in AML
James Marvin et al.
BLOOD (2011)
Comprehensive analysis of kinase inhibitor selectivity
Mindy I. Davis et al.
NATURE BIOTECHNOLOGY (2011)
Physiological Jak2V617F Expression Causes a Lethal Myeloproliferative Neoplasm with Differential Effects on Hematopoietic Stem and Progenitor Cells
Ann Mullally et al.
CANCER CELL (2010)
Tyrosines 868, 966, and 972 in the Kinase Domain of JAK2 Are Autophosphorylated and Required for Maximal JAK2 Kinase Activity
Lawrence S. Argetsinger et al.
MOLECULAR ENDOCRINOLOGY (2010)
A Phase I Study of the Mammalian Target of Rapamycin Inhibitor Sirolimus and MEC Chemotherapy in Relapsed and Refractory Acute Myelogenous Leukemia
Alexander E. Perl et al.
CLINICAL CANCER RESEARCH (2009)
The RON receptor tyrosine kinase regulates IFN-γ production and responses in innate immunity
Caleph B. Wilson et al.
JOURNAL OF IMMUNOLOGY (2008)
A novel Stat3 binding motif in Gab2 mediates transformation of primary hematopoietic cells by the Stk/Ron receptor tyrosine kinase in response to friend virus infection
Shuang Ni et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Expression of Jak2V617F causes a polycythemia vera-like disease with associated myelofibrosis in a murine bone marrow transplant model
Gerlinde Wernig et al.
BLOOD (2006)
GRB2-mediated recruitment of GAB2, but not GAB1, to SF-STK supports the expansion of Friend virus-infected erythroid progenitor cells
HE Teal et al.
ONCOGENE (2006)
Whole blood fixation and permeabilization protocol with red blood cell lysis for flow cytometry of intracellular phosphorylated epitopes in leukocyte subpopulations
S Chow et al.
CYTOMETRY PART A (2005)
Tyrosine kinase receptor RON functions downstream of the erythropoietin receptor to induce expansion of erythroid progenitors
E van den Akker et al.
BLOOD (2004)
Sf-Stk kinase activity and the Grb2 binding site are required for Epo-independent growth of primary erythroblasts infected with Friend virus
LD Finkelstein et al.
ONCOGENE (2002)
分享论文
